Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in metastatic transitional cell carcinoma of the urothelium
NCT00805129Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2008
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in urothelial carcinoma (UC), sponsored by Memorial Sloan Kettering Cancer Center. Started Dec 2008; status: completed.
02
Drugs
everolimus
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00805129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805129.